Inventor · disambiguated record
Maksim Osipov
Also filed as: OSIPOV MAKSIM
24 granted patents·18 pending applications·51 citations·filing 2015–2025
93Inventor score
Files withDENALI THERAPEUTICS INC23FLEXUS BIOSCIENCES INC8BRISTOL MYERS SQUIBB CO5NICO THERAPEUTICS INC4RAPT THERAPEUTICS INC1
Top patents by PatentIndex Score
42 records- 0196US9643972B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2015·Granted May 9, 2017·15 cites·47 claims
- 0296US9598422B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2015·Granted Mar 21, 2017·21 cites·34 claims
- 0393US10106546B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2017·Granted Oct 23, 2018·6 cites·66 claims
- 0491US11306077B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Apr 19, 2022·2 cites·47 claims
- 0589US10533014B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2018·Granted Jan 14, 2020·3 cites·20 claims
- 0683US11203600B2Kinase inhibitors and uses thereofDENALI THERAPEUTICS INC·Filed 2019·Granted Dec 21, 2021·2 cites·24 claims
- 0780US11236100B2Modulators of eukaryotic initiation factor 2B, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Feb 1, 2022·1 cites·30 claims
- 0880US2025011338A1Kinase Inhibitors and Uses ThereofDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0979US2024140919A1Modulators of eukaryotic initiation factor 2DENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1076US2023250072A1Modulators of eukaryotic initiation factor 2DENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1175US11851440B2Modulators of eukaryotic initiation factor 2B, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Dec 26, 2023·0 cites·18 claims
- 1275US2025122159A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1373US12139478B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Nov 12, 2024·1 cites·57 claims
- 1472US2022127233A1Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparationBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1570US11919863B2Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparationBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Mar 5, 2024·0 cites·17 claims
- 1669US12421195B2Amorphous and crystalline forms of IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 23, 2025·0 cites·12 claims
- 1769US12180211B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Dec 31, 2024·0 cites·5 claims
- 1869US12129263B2Kinase inhibitors and uses thereofDENALI THERAPEUTICS INC·Filed 2021·Granted Oct 29, 2024·0 cites·19 claims
- 1968US11958840B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2022·Granted Apr 16, 2024·0 cites·45 claims
- 2067US11851433B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Dec 26, 2023·0 cites·17 claims
- 2166US11932601B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2021·Granted Mar 19, 2024·0 cites·17 claims
- 2265US11072618B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2019·Granted Jul 27, 2021·0 cites·17 claims
- 2365US2025388595A1Modulators of eukaryotic initiation factor 2b, compositions and methodsDENALI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2464US2021130308A1Modulators of eukaryotic initiation factor 2DENALI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2563US11236049B2Amorphous and crystalline forms of IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 1, 2022·0 cites·4 claims
- 2661US11236048B2Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparationBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 1, 2022·0 cites·16 claims
- 2761US2025361234A1Compounds, compositions, and methodsNICO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2860US12091392B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2020·Granted Sep 17, 2024·0 cites·9 claims
- 2959US2025171462A1Compounds, compositions, and methodsNICO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3059US2025145592A1Compounds, compositions, and methodsNICO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3159US2025197399A1Compounds, compositions, and methodsTENVIE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3258US2024391932A1Compounds, compositions and methodsNICO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3358US2024254132A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3457US11242319B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2015·Granted Feb 8, 2022·0 cites·23 claims
- 3556US10206893B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2017·Granted Feb 19, 2019·0 cites·23 claims
- 3655US11174262B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2019·Granted Nov 16, 2021·0 cites·16 claims
- 3754US2023357162A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3853US2023348437A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3953US2023416205A1Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4049US2022177456A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4148US2021317134A1Ubiquitin-specific-processing protease 7 (usp7) modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4242US10987322B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2015·Granted Apr 27, 2021·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Maksim Osipov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →